Ukraine

2022 was a complicated year. Global challenges like the Ukraine war and the continued impact of Covid-19 have been felt across the world. And yet it was also a year of incredible innovation in drug discovery, with the potential of new biotechnology beginning to be revealed. Our top 10 most popular online articles for 2022 […]

Following the news that the number of clinical trial recruiting sites in Ukraine has dropped by half since the Russian invasion, DDW’s Diana Spencer examines clinical trial data from analytics company Phesi and speaks to Dr Olena Karpenko, Clinical Research Director at Medical Center Ok!Clinic+ to understand the impact of the war and how the […]

New global data analysis from Phesi shows the extent of the impact from the war in Ukraine on clinical development.   Phesi analysed pivotal trials sponsored by pharmaceutical companies that represent the most critical global clinical development activities.   The findings  The findings show that as of March 16, 2022, there were 65,593 recruiting investigator sites globally […]

James Tyrrell, Chair, Global Health, APCO Worldwide, assesses the pharmaceutical industry’s response to the Russian invasion of Ukraine and its ramifications on the sector.     With no quick end to Russia’s invasion of Ukraine, life sciences companies are increasingly being challenged to navigate this complex geopolitical crisis. Pharma and medtech companies’ products are not bound […]